Compare ATOS & KAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATOS | KAZR |
|---|---|---|
| Founded | 2009 | 2024 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9M | 23.1M |
| IPO Year | 2010 | 2024 |
| Metric | ATOS | KAZR |
|---|---|---|
| Price | $2.07 | $1.15 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | 73.9K | ★ 175.4K |
| Earning Date | 11-10-2026 | 08-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,758.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $0.92 |
| 52 Week High | $7.56 | $3.20 |
| Indicator | ATOS | KAZR |
|---|---|---|
| Relative Strength Index (RSI) | 39.61 | 31.09 |
| Support Level | $1.76 | $0.92 |
| Resistance Level | $2.60 | $2.43 |
| Average True Range (ATR) | 0.18 | 0.24 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 7.47 | 27.04 |
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
Skyline Builders Group Holding Ltd is a holding company that operates through its subsidiary. It is a Public Works Contractor company undertaking roads and drainage in Hong Kong. Its construction activities mainly include public civil engineering works, such as road and drainage works, in Hong Kong.